Meg Elias
Corporate Officer/Principal en ARCUTIS BIOTHERAPEUTICS, INC. .
Perfil
Meg Elias is currently the Vice President of Clinical Operations at Arcutis Biotherapeutics, Inc. Her former position was as Head of Clinical Operations at Kite Pharma, Inc. She received her undergraduate degree from Cedar Crest College.
Cargos activos de Meg Elias
| Empresas | Cargo | Inicio |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2019 |
Antiguos cargos conocidos de Meg Elias.
| Empresas | Cargo | Fin |
|---|---|---|
| KITE PHARMA INC | Corporate Officer/Principal | 01/12/2018 |
Formación de Meg Elias.
| Cedar Crest College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 1 |
|---|---|
Kite Pharma, Inc.
 Kite Pharma, Inc. BiotechnologyHealth Technology Kite Pharma, Inc. engages in the the development and commercialization of cancer immunotherapy products. Its products include chimeric antigen receptor (CAR) and T cell receptor (TCR), which address both hematological and solid cancers. The company was founded by Arie S. Belldegrun, James S. Economou, and Joshua A. Kazam on 2009 and is headquartered in Santa Monica, CA. | Health Technology |
- Bolsa de valores
- Insiders
- Meg Elias
